Literature DB >> 6469965

Metabolism of proteoglycans in rat ovarian granulosa cell culture. Multiple intracellular degradative pathways and the effect of chloroquine.

M Yanagishita, V C Hascall.   

Abstract

The metabolism of endogenously labeled proteoglycans was studied in rat ovarian granulosa cell cultures by a series of pulse-chase experiments using [35S]sulfate as a precursor. More than 90% of the newly synthesized proteoglycans are transported to the cell surface (trypsin-accessible compartment) with a median transit time of 13 min. The membrane-bound heparan sulfate-proteoglycan (HS-PG) is lost from the cell surface either by release into the medium (30%, with t1/2 of 4 h) or by internalization (70%, with t1/2 of 4 h). Internalized HS-PG, which does not recycle to the cell surface, is degraded by two major pathways. In pathway 1, 60% of the internalized HS-PG migrates to lysosomes with a relatively short t1/2 of 30 min, where it is rapidly degraded, releasing free [35S]sulfate without detectable intermediate products. Chloroquine treatment inhibited degradation, resulting in the accumulation of intact proteoglycans inside the cell. In pathway 2, 40% of the internalized HS-PG is first subjected to extensive proteolysis and limited endoglycosidic degradation yielding single HS chains about 1/3 of their original size (t1/2 of 30 min). Chloroquine did not inhibit this step. The partially degraded HS is then degraded further by limited endoglycosidic activity to about 1/4-1/5 the original size (t1/2 of 30-60 min). This step is inhibited by chloroquine. These smaller fragments have a relatively long t1/2 of 3-4 h before rapid degradation in the lysosomes, releasing free [35S]sulfate. Approximately 7% of the newly synthesized HS-PG that is not transported to the cell surface is degraded directly by pathway 2. The larger dermatan sulfate proteoglycan (DS-I) is transported to the cell surface from which it is quantitatively released into the medium with a t1/2 of 4-6 h. The smaller DS-PG (DS-II) is metabolized similarly to the HS-PG. Most (greater than 90%) is transported to the cell surface from which it is lost either by release into the medium (40%) or by internalization (60%). About 60% of the internalized DS-II is degraded by pathway 1 (t1/2 of 30 min), while the remainder appears to be degraded by pathway 2 with an overall t1/2 of 4 h. However, in contrast to the degradation of HS-PG by pathway 2, no endoglycosidic degradation of the DS chains occurred.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469965

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Isolation and characterization of proteoglycans synthesized by mouse osteoblastic cells in culture during the mineralization process.

Authors:  Y Takeuchi; T Matsumoto; E Ogata; Y Shishiba
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

2.  Basement membrane heparan sulfate proteoglycan is the main proteoglycan synthesized by glomerular epithelial cells in culture.

Authors:  J L Stow; C J Soroka; K MacKay; L Striker; G Striker; M G Farquhar
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

3.  Heparan Sulfate Regrowth Profiles Under Laminar Shear Flow Following Enzymatic Degradation.

Authors:  Kristina M Giantsos-Adams; Andrew Jia-An Koo; Sukhyun Song; Jiro Sakai; Jagadish Sankaran; Jennifer H Shin; Guillermo Garcia-Cardena; C Forbes Dewey
Journal:  Cell Mol Bioeng       Date:  2013-02-20       Impact factor: 2.321

4.  Proteoglycans synthesized by an osteoblast-like cell line (UMR 106-01).

Authors:  D J McQuillan; D M Findlay; A M Hocking; M Yanagishita; R J Midura; V C Hascall
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

5.  Evidence that platelet and tumour heparanases are similar enzymes.

Authors:  C Freeman; A M Browne; C R Parish
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

6.  Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.

Authors:  S Tumova; B A Hatch; D J Law; K J Bame
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

7.  Brefeldin A inhibits the endocytosis of plasma-membrane-associated heparan sulphate proteoglycans of cultured rat ovarian granulosa cells.

Authors:  L Uhlin-Hansen; M Yanagishita
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Receptor-mediated magnetic carriers: basis for targeting.

Authors:  J M Gallo; E E Hassan
Journal:  Pharm Res       Date:  1988-05       Impact factor: 4.200

9.  Chondroitin sulphate proteoglycan in the substratum adhesion sites of Balb/c 3T3 cells. Fractionation on various ion-exchange and affinity columns.

Authors:  B C Wightman; E A Weltman; L A Culp
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

10.  ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican.

Authors:  Anders Wittrup; Si-He Zhang; Gerdy B ten Dam; Toin H van Kuppevelt; Per Bengtson; Maria Johansson; Johanna Welch; Matthias Mörgelin; Mattias Belting
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.